Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects

The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression

(2013) Ann Allen   CLINICAL PHARMACOKINETICS

Fluticasone Furoate, a Novel Inhaled Corticosteroid, Demonstrates Prolonged Lung Absorption Kinetics in Man Compared with Inhaled Fluticasone Propionate

(2012) Ann Allen et al.   CLINICAL PHARMACOKINETICS

Effect of Once-Daily Fluticasone Furoate/Vilanterol on 24-Hour Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease: A Randomized, Three-Way, Incomplete Block, Crossover Study

(2012) Joseph A. Boscia et al.   CLINICAL THERAPEUTICS

Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial

(2012) Eric D. Bateman et al.   RESPIRATORY MEDICINE

Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial

(2012) J Lötvall et al.   BMJ Open

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial

(2011) William W Busse et al.   THORAX

Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations

(2008) SP Myrand et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Metabolism and Disposition of Fluticasone Furoate, an Enhanced-Affinity Glucocorticoid, in Humans

(2008) S. C. Hughes et al.   DRUG METABOLISM AND DISPOSITION